These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11688968)

  • 81. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
    Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
    J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
    Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
    Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases.
    Allen-Mersh TG; Glover C; Fordy C; Mathur P; Quinn H
    Eur J Surg Oncol; 2000 Aug; 26(5):468-73. PubMed ID: 11016468
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [The evaluation of weekly hepatic arterial infusion of high-dose 5-FU for liver metastases from colorectal cancer].
    Hata Y; Morita S; Noda Y; Kawasaki R; Morita Y; Awatani T; Horimi T
    Gan To Kagaku Ryoho; 1998 May; 25(6):901-5. PubMed ID: 9617329
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical pharmacokinetics of capecitabine.
    Reigner B; Blesch K; Weidekamm E
    Clin Pharmacokinet; 2001; 40(2):85-104. PubMed ID: 11286326
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
    Howell JD; Warren HW; Anderson JH; Kerr DJ; McArdle CS
    Eur J Surg; 1999 Jul; 165(7):652-8. PubMed ID: 10452259
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma.
    Meropol NJ; Petrelli NJ; Rustum YM; Rodriguez-Bigas M; Blumenson LE; Frank C; Berghorn E; Creaven PJ
    Invest New Drugs; 1995; 13(2):149-55. PubMed ID: 8617578
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients.
    Teh LK; Hamzah S; Hashim H; Bannur Z; Zakaria ZA; Hasbullani Z; Shia JK; Fijeraid H; Md Nor A; Zailani M; Ramasamy P; Ngow H; Sood S; Salleh MZ
    Ther Drug Monit; 2013 Oct; 35(5):624-30. PubMed ID: 23942539
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases.
    Anaya DA; Dogra P; Wang Z; Haider M; Ehab J; Jeong DK; Ghayouri M; Lauwers GY; Thomas K; Kim R; Butner JD; Nizzero S; Ramírez JR; Plodinec M; Sidman RL; Cavenee WK; Pasqualini R; Arap W; Fleming JB; Cristini V
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33503971
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens.
    Nacev A; Kim SH; Rodriguez-Canales J; Tangrea MA; Shapiro B; Emmert-Buck MR
    Int J Nanomedicine; 2011; 6():2907-23. PubMed ID: 22131836
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Pharmacology of regional chemotherapy of colorectal liver metastases].
    Schalhorn A; Kühl M
    Zentralbl Chir; 1995; 120(10):764-8. PubMed ID: 7502590
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model.
    Burke D; Carnochan P; Glover C; Allen-Mersh TG
    Clin Exp Metastasis; 2000; 18(7):617-22. PubMed ID: 11688968
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of regional angiotensin II infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model.
    Dworkin MJ; Zweit J; Carnochan P; Deehan B; Allen-Mersh TG
    Eur J Cancer; 1996 Aug; 32A(9):1580-4. PubMed ID: 8911121
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases.
    Shankar A; Loizidou M; Burnstock G; Taylor I
    Br J Surg; 1999 Apr; 86(4):453-7. PubMed ID: 10215813
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.
    Gupta N; Saleem A; Kötz B; Osman S; Aboagye EO; Phillips R; Vernon C; Wasan H; Jones T; Hoskin PJ; Price PM
    Clin Cancer Res; 2006 May; 12(10):3115-23. PubMed ID: 16707610
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
    Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ
    Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.